Impact of the SARS-CoV-2 Virus Pandemic on Patients with Bronchiectasis: A Multicenter Study.
Adrian Martinez-VergaraRosa María GirónCasilda OlveiraMaría Victoria GirónAdrián PeláezJulio AncocheaFernando Santamaría-MartosMiguel Ángel Martínez-GarcíaPublished in: Antibiotics (Basel, Switzerland) (2022)
During the SARS-CoV-2 period, a significant reduction was observed in the exacerbations, severity, and isolations of pathogenic microorganisms in patients with bronchiectasis.